January 19, 2025 - 20:09

The president-elect announced on Sunday plans to sign an executive order concerning TikTok, indicating a potential shift in the app's status in the United States. The proposed order aims to "extend the period of time before the law's prohibitions take effect," which could open the door for the popular social media platform to continue operating within the country.
This move comes amidst ongoing discussions about national security and data privacy concerns surrounding TikTok, which has faced scrutiny from lawmakers and regulators. The executive order could provide a temporary reprieve for the app, allowing time for further evaluation of its operations and data handling practices.
Supporters of the app argue that it offers a valuable platform for creativity and communication, while critics remain wary of its ties to foreign ownership and potential risks to user data. The president-elect's decision to revisit the TikTok issue reflects a broader trend of reassessing technology policies as the administration prepares to take office.
May 16, 2026 - 00:10
Blake's Snow Shack owned by man with Down syndrome in Texas turns 10In the small North Texas town of Sanger, a beloved local business is marking a sweet anniversary. Blake`s Snow Shack, a shaved ice stand owned and operated by a man with Down syndrome, is turning...
May 15, 2026 - 04:31
SBA Launches Small Business Pitch Competition » CBIAThe U.S. Small Business Administration has announced a new pitch competition aimed at companies that show strong innovation and have a track record of using SBA-backed financing tools. The contest...
May 14, 2026 - 01:02
INOVIO Reports First Quarter 2026 Financial Results and Recent Business HighlightsINOVIO has released its financial results for the first quarter of 2026, alongside a summary of recent business developments. The company`s primary focus remains on the regulatory path for its lead...
May 13, 2026 - 04:15
Curis Provides First Quarter 2026 Business UpdateCuris, Inc., a biotechnology company advancing the development of its lead drug candidate emavusertib, provided a business update for the first quarter of 2026. The company is focused on...